NOVEL IN-VITRO METHOD FOR IDENTIFICATION OF INDIVIDUALS AT RISK FOR BERYLLIUM HYPERSENSITIVITY

Beryllium-specific lymphocytes were generated by in vitro immunization of peripheral brood mononuclear cells (PBMC) from healthy unexposed i ndividuals. Measurement of blastogenic responses of PBMC by [H-3] thym idine uptake demonstrated that sensitization of PBMC with beryllium sa lts followed by stimulation with unrelated salts resulted in a negativ e response, whereas sensitization and restimulation of PBMC with beryl lium salts produced a positive response. Flow cytometric and cell depl etion analyses showed that all of the responding cells were CD4(+) T c ells. The in vitro immunization system was used to screen 52 human sub jects for susceptibility to beryllium sensitization in vitro. The resu lts show that of the 52 healthy unexposed subjects tested, only 1 (2%) was highly responsive, 4 subjects (8%) were moderately responsive, 20 subjects (39%) were low-level responders, and 27 subjects (52%) were nonresponders. The results showing 2% high-level responsiveness to ber yllium sensitization in vitro correlate with the 1 to 5% prevalence of chronic beryllium disease in individuals sensitized to beryllium dust in vivo and thus support the thesis that the in vitro immunization sy stem may permit the identification of individuals at risk for berylliu m hypersensitivity.